Abstract Background Sub-Saharan Africa (SSA) has the highest burden of HIV in the world
and a rising prevalence of cardiometabolic disease; however, the interrelationship between …

Background Antiretroviral drugs increase biosynthesis and reduce hepatic clearance of
serum cholesterol. It is thus important to evaluate the impact of antiretroviral treatment on …

Background Data on lipid profile abnormalities among patients receiving highly active
antiretroviral treatment in Ethiopia are very limited. The aim of this study was to determine …

Background With increasing adverse cardiovascular disease (CVD) outcomes in HIV/AIDS
patients, the possible contribution of antiretroviral therapy (ART) to the prevailing CVD …

Although more than one in two HIV-infected persons may develop central fat accumulation
soon after commencing antiretroviral therapy, the association between antiretroviral therapy …

Background: The introduction of highly active antiretroviral therapy (HAART) has led to
significant reduction in acquired immune deficiency syndrome (AIDS) related to morbidity …

ABSTRACT Introduction: Human Immunodeficiency Virus (HIV) is a lentivirus that breaks
down the body's immune system, causing Acquired Immune Deficiency Syndrome (AIDS) …

Aims: This study set out to assess therapy induced lipid profile changes among patients on
HAART in Kano North-Western Nigeria. Design: Cross-sectional. Settings: This study was …

Objectives: Highly active antiretroviral (HAART) drugs have increased the life expectancy
and quality of life of HIV patients. However, to sustain viral suppression, HAART drugs have …

Patients infected with HIV have an increased risk of developing heart disease. HIV causes
Acquired Immune Deficiency Syndrome AIDS by invading the host cells and depleting the …